The yellow fever outbreak that began in Viana, Luanda province, Angola last December has grown to more than 1,000 cases nationwide, according to a World Health Organization update.
As of 21 March, 16 of the country’s 18 provinces have reported YF suspected cases – 13 of these provinces have reported imported cases linked to Luanda. Local transmission of the disease was documented in 2 of the 11 municipalities of Huambo province. Other provinces have reported autochthonous suspected cases with no epidemiological links to Luanda.
To date, at least 1,132 suspected and confirmed cases have been reported nationally, including 168 deaths. A total of 375 cases have been laboratory-confirmed. Luanda, the outbreak epicentre, remains the main affected province with 818 cases (281 confirmed confirmed), including 129 deaths. However, the number of cases reported in provinces other than Luanda is apparently increasing.
On 12 February, WHO declared this outbreak a “grade 2 emergency”, in accordance with the Emergency Response Framework (ERF). Since then, 65 WHO multidisciplinary experts have been deployed to provide high-level technical support to the country.
The Immunization campaign in Luanda, which started on 2 February in Viana, is still ongoing and has so far been implemented in 6 municipalities out of the targeted 12.
Three municipalities are reporting high coverage rates (≥90%) while other municipalities are reporting even higher rates (136% in Viana and 113% in Bela) probably due to people coming from other districts of Luanda as well as other provinces.
Yellow fever is a viral disease, found in tropical regions of Africa and the Americas. The “yellow” in the name refers to the jaundice that affects some patients. It principally affects humans and monkeys, and is transmitted via the bite of Aedes mosquitoes. It can produce devastating outbreaks, which can be prevented and controlled by mass vaccination campaigns.
Large scale outbreaks occur every 3 to 10 years in villages or cities in the absence of large scale immunization. Sporadic cases can occur regularly in endemic areas.
The incubation period of the virus is 3 to 6 days after a bite from an infected mosquito. About 15% of infections progress to fever and jaundice. While only the minority of cases are severe, case fatality rate may be 25% to 50% among patients with syndrome of haemorrhage, jaundice, and renal disease.
Vaccination is the most important preventive measure against yellow fever. The vaccine is safe, affordable and highly effective. A single dose of yellow fever vaccine is sufficient to confer sustained immunity and life-long protection against yellow fever disease and a booster dose of yellow fever vaccine is not needed. The vaccine provides effective immunity within 30 days for 99% of persons vaccinated.
- Zika vaccine: University of Manchester researchers to develop
- Norovirus: Scores sickened on Norwegian Gem
- Outbreak News: Elizabethkingia anophelis and Lassa fever (podcast)